Several outlets are highlighting biotech stocks as potential buys in 2026, with some specifically recommending certain stocks for their potential for buyouts or due to new drug data. There appears to be a general interest in biotech stocks for the remainder of the year, with some sources identifying top stocks to watch or buy. However, the specific stocks and investment strategies being recommended vary across the different outlets.